Autologous blood derived cell therapy in maxillofacial bone graft surgery
- 대한구강악안면외과학회
- 대한구강악안면외과학회지
- 대한구강악안면외과학회지 제47권 제6호
-
2021.12480 - 483 (4 pages)
-
DOI : 10.5125/jkaoms.2021.47.6.480
- 0

Tissue regeneration is one of the ultimate goals of maxillofacial surgery and various types of tissue engineering technologies have been utilized in clin-ics. Healthy resources of host cells and growth factors are essential for the tissue engineering, therefore autologous blood-derived cell therapy was in-troduced. In this article, clinical applications of the autologous platelet concentrates and stem cell separation therapy will be summarized and evaluated for their efficacy and feasibility in the current maxillofacial clinics.
I. Introduction
II. Types of Clinically Available Autologous Blood Derived Cell Therapy
III. Controversies in Usage of Autologous Blood Derived Cell Therapy in Maxillofacial Surgery
IV. Summary and Editor’s Opinion
Author’s Contributions
Conflict of Interest
References
(0)
(0)